Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,808
Sort by:
The 2027-2032 World Outlook for DNA Polymerase
US$ 1,195.00
This study covers the world outlook for DNA polymerase across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for DNA Sequencing
US$ 1,195.00
This study covers the world outlook for DNA sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for DNA Sequencing Diagnostics
US$ 1,195.00
This study covers the world outlook for DNA sequencing diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Gene Panels
US$ 1,195.00
This study covers the world outlook for gene panels across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Genetic Sequencing Tests
US$ 1,195.00
This study covers the world outlook for genetic sequencing tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Genome Sequencing
US$ 1,195.00
This study covers the world outlook for genome sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Genotyping Assays
US$ 1,195.00
This study covers the world outlook for genotyping assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Glass Bioactive Materials
US$ 1,195.00
This study covers the world outlook for glass bioactive materials across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Human Embryonic Stem Cells
US$ 1,195.00
This study covers the world outlook for human embryonic stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for In Situ Hybridization
US$ 1,195.00
This study covers the world outlook for in situ hybridization across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Induced Pluripotent
US$ 1,195.00
This study covers the world outlook for induced pluripotent across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Injectable Nanomedicines
US$ 1,195.00
This study covers the world outlook for injectable nanomedicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Liver Organs-on-Chips
US$ 1,195.00
This study covers the world outlook for liver organs-on-chips across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Long Read Sequencing
US$ 1,195.00
This study covers the world outlook for long read sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Micro-Sized Hydroxyapatite
US$ 1,195.00
This study covers the world outlook for micro-sized hydroxyapatite across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Nanomedicines
US$ 1,195.00
This study covers the world outlook for nanomedicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
288 pages
The 2027-2032 World Outlook for Native Collagen
US$ 1,195.00
This study covers the world outlook for native collagen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Neurological Biomarkers
US$ 1,195.00
This study covers the world outlook for neurological biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Regenerative Medicines
US$ 1,195.00
This study covers the world outlook for regenerative medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
289 pages
The 2027-2032 World Outlook for Renal Biomarkers
US$ 1,195.00
This study covers the world outlook for renal biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for RNA-Based Therapeutics
US$ 1,195.00
This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for RNA Therapeutics
US$ 1,195.00
This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for RNAi Technologies
US$ 1,195.00
This study covers the world outlook for RNAi technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for RNAi Therapeutics
US$ 1,195.00
This study covers the world outlook for RNAi therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages